Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi-Un Pae

Showing results (251-260 of 387) with videos related to

Pageof 39
Sort By:
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|April 22, 2009
History of early abuse as a predictor of treatment response in patients with fibromyalgia: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled releaseChi-Un Pae, Prakash S Masand, David M Marks, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 24, 2007
Fluoxetine versus sertraline in the treatment of patients with undifferentiated somatoform disorder: a randomized, open-label, 12-week, parallel-group trialChangsu Han, Chi-Un Pae, Bun Hee Lee, et al.
Chonnam Medical Journal|February 12, 2019
Erratum: Correction of Acknowledgements Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An UpdateSheng-Min Wang, Changsu Han, Soo-Jung Lee, et al.
Expert Review of Neurotherapeutics|February 4, 2015
Curcumin as a putative antidepressantHo-Jun Seo, Sheng-Min Wang, Changsu Han, et al.
Clinical Neuropharmacology|January 19, 2011
Safety and tolerability of lamotrigine: results from 12 placebo-controlled clinical trials and clinical implicationsHo-Jun Seo, Alberto Chiesa, Soo-Jung Lee, et al.
Journal of Psychiatric Research|April 18, 2020
Comparative efficacy and acceptability of pharmacological interventions for the treatment and prevention of delirium: A systematic review and network meta-analysisMin Seo Kim, Hye Chang Rhim, Ariel Park, et al.
Advances in Therapy|February 2, 2017
The Impact of a Single Nucleotide Polymorphism in SIGMAR1 on Depressive Symptoms in Major Depressive Disorder and Bipolar DisorderLaura Mandelli, Sheng-Min Wang, Changsu Han, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|July 10, 2023
The Impact of COVID-19 on Psychiatric Health in the Korean PopulationSheng-Min Wang, Sung-Hwan Kim, Won-Seok Choi, et al.
Journal of Korean Medical Science|August 15, 2014
The influence of depression, anxiety and somatization on the clinical symptoms and treatment response in patients with symptoms of lower urinary tract symptoms suggestive of benign prostatic hyperplasiaYong June Yang, Jun Sung Koh, Hyo Jung Ko, et al.
Psychiatry Investigation|May 2, 2022
Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative StudySeung-Hoon Lee, Sang Won Jeon, Cheolmin Shin, et al.
Pageof 39

Showing results (251-260 of 387) with videos related to

Sort By:
Pageof 39
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|April 22, 2009
History of early abuse as a predictor of treatment response in patients with fibromyalgia: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled releaseChi-Un Pae, Prakash S Masand, David M Marks, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 24, 2007
Fluoxetine versus sertraline in the treatment of patients with undifferentiated somatoform disorder: a randomized, open-label, 12-week, parallel-group trialChangsu Han, Chi-Un Pae, Bun Hee Lee, et al.
Chonnam Medical Journal|February 12, 2019
Erratum: Correction of Acknowledgements Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An UpdateSheng-Min Wang, Changsu Han, Soo-Jung Lee, et al.
Expert Review of Neurotherapeutics|February 4, 2015
Curcumin as a putative antidepressantHo-Jun Seo, Sheng-Min Wang, Changsu Han, et al.
Clinical Neuropharmacology|January 19, 2011
Safety and tolerability of lamotrigine: results from 12 placebo-controlled clinical trials and clinical implicationsHo-Jun Seo, Alberto Chiesa, Soo-Jung Lee, et al.
Journal of Psychiatric Research|April 18, 2020
Comparative efficacy and acceptability of pharmacological interventions for the treatment and prevention of delirium: A systematic review and network meta-analysisMin Seo Kim, Hye Chang Rhim, Ariel Park, et al.
Advances in Therapy|February 2, 2017
The Impact of a Single Nucleotide Polymorphism in SIGMAR1 on Depressive Symptoms in Major Depressive Disorder and Bipolar DisorderLaura Mandelli, Sheng-Min Wang, Changsu Han, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|July 10, 2023
The Impact of COVID-19 on Psychiatric Health in the Korean PopulationSheng-Min Wang, Sung-Hwan Kim, Won-Seok Choi, et al.
Journal of Korean Medical Science|August 15, 2014
The influence of depression, anxiety and somatization on the clinical symptoms and treatment response in patients with symptoms of lower urinary tract symptoms suggestive of benign prostatic hyperplasiaYong June Yang, Jun Sung Koh, Hyo Jung Ko, et al.
Psychiatry Investigation|May 2, 2022
Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative StudySeung-Hoon Lee, Sang Won Jeon, Cheolmin Shin, et al.
Pageof 39